These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8887884)

  • 1. Effects of cisplatin on erythropoietin production in rats.
    Unami A; Nishina N; Terai T; Sato S; Tamura T; Noda K; Mine Y
    J Toxicol Sci; 1996 Aug; 21(3):157-65. PubMed ID: 8887884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythropoietin ameliorates anemia of cisplatin induced acute renal failure.
    Baldwin MD; Zhou XJ; Ing TS; Vaziri ND
    ASAIO J; 1998; 44(1):44-7. PubMed ID: 9466500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of anemia and its relationship with renal function, blood pressure, and erythropoietin in rats with chronic kidney disease.
    Phillips JK; Boyd R; Krockenberger MB; Burgio G
    Vet Clin Pathol; 2015 Sep; 44(3):342-54. PubMed ID: 26292198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin-associated anemia: an erythropoietin deficiency syndrome.
    Wood PA; Hrushesky WJ
    J Clin Invest; 1995 Apr; 95(4):1650-9. PubMed ID: 7706473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of recombinant human erythropoietin (SNB-5001) on renal anemic rats induced by drugs].
    Masunaga H; Takahira R; Sawai T
    Nihon Yakurigaku Zasshi; 1991 Aug; 98(2):151-60. PubMed ID: 1916543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of erythropoietin against cisplatin-induced nephrotoxicity in rats: antigenotoxic and antiapoptotic effect.
    Rjiba-Touati K; Ayed-Boussema I; Bouaziz C; Belarbia A; Azzabi A; Achour A; Hassen W; Bacha H
    Drug Chem Toxicol; 2012 Jan; 35(1):89-95. PubMed ID: 21834728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadmium and cisplatin damage erythropoietin-producing proximal renal tubular cells.
    Horiguchi H; Oguma E; Kayama F
    Arch Toxicol; 2006 Oct; 80(10):680-6. PubMed ID: 16555044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia.
    Landau D; London L; Bandach I; Segev Y
    PLoS One; 2018; 13(5):e0196684. PubMed ID: 29738538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury.
    Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin enhances recovery from cisplatin-induced acute renal failure.
    Vaziri ND; Zhou XJ; Liao SY
    Am J Physiol; 1994 Mar; 266(3 Pt 2):F360-6. PubMed ID: 8160783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of erythropoietin in prevention of amikacin-induced nephropathy.
    Kaynar K; Aliyazioglu R; Ersoz S; Ulusoy S; Al S; Ozkan G; Cansiz M
    J Nephrol; 2012; 25(5):744-9. PubMed ID: 22322815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythropoietin reduces cumulative nephrotoxicity from cisplatin and enhances renal tubular cell proliferation.
    Zafirov D; Petrusevska G; Sikole A; Trojacanec J; Labacevski N; Kostova E; Jakovski K; Atanasovska E; Petrov S
    Prilozi; 2008 Dec; 29(2):167-83. PubMed ID: 19259045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-treatment effects of erythropoietin and nordihydroguaiaretic acid on recovery from cisplatin-induced acute renal failure in the rat.
    Lee DW; Kwak IS; Lee SB; Song SH; Seong EY; Yang BY; Lee MY; Sol MY
    J Korean Med Sci; 2009 Jan; 24 Suppl(Suppl 1):S170-5. PubMed ID: 19194548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased plasma viscosity as a reason for inappropriate erythropoietin formation.
    Singh A; Eckardt KU; Zimmermann A; Götz KH; Hamann M; Ratcliffe PJ; Kurtz A; Reinhart WH
    J Clin Invest; 1993 Jan; 91(1):251-6. PubMed ID: 8423222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Failure to confirm a sodium-glucose cotransporter 2 inhibitor-induced hematopoietic effect in non-diabetic rats with renal anemia.
    Yamazaki D; Konishi Y; Morikawa T; Kobara H; Masaki T; Hitomi H; Osafune K; Nakano D; Kittikulsuth W; Nishiyama A
    J Diabetes Investig; 2020 Jul; 11(4):834-843. PubMed ID: 31880858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative assessment of erythropoiesis and functional classification of anemia based on measurements of serum transferrin receptor and erythropoietin.
    Beguin Y; Clemons GK; Pootrakul P; Fillet G
    Blood; 1993 Feb; 81(4):1067-76. PubMed ID: 8427988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel approach to adenine-induced chronic kidney disease associated anemia in rodents.
    Rahman A; Yamazaki D; Sufiun A; Kitada K; Hitomi H; Nakano D; Nishiyama A
    PLoS One; 2018; 13(2):e0192531. PubMed ID: 29415057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Erythropoietin production in rats with post-ischemic acute renal failure.
    Tan CC; Tan LH; Eckardt KU
    Kidney Int; 1996 Dec; 50(6):1958-64. PubMed ID: 8943479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired biological activity of erythropoietin by cyanate carbamylation.
    Mun KC; Golper TA
    Blood Purif; 2000; 18(1):13-7. PubMed ID: 10686438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pretreatment with darbepoetin attenuates renal injury in a rat model of cisplatin-induced nephrotoxicity.
    Choi DE; Jeong JY; Lim BJ; Lee KW; Shin YT; Na KR
    Korean J Intern Med; 2009 Sep; 24(3):238-46. PubMed ID: 19721861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.